Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer

Conclusion Serum CAF profiling differentiated GC patient groups. A high 11-CAF signature could identify GC patients with a poor prognosis when treated with standard chemotherapy who need urgent new treatment strategies.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research